Hebei Changshan Biochemical Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of crude heparin, heparin raw materials, and heparin preparations for the treatment of cardiovascular and cerebrovascular diseases in China and internationally. It offers crude heparin sodium, heparin sodium raw materials, heparin sodium injections, low molecular weight heparin calcium raw materials and injections, enoxaparin sodium raw materials and injections, nadri heparin calcium API, nandroparin calcium injection, and dalteparin sodium API and injection. The company was founded in 2000 and is based in Shijiazhuang, China.

Sector

Healthcare

Industry

Biotechnology

CEO

Gao, Xiaodong

Employees

1,254

Website

www.hbcsbio.com

IPO Date

2011-08-19

Headquarters

Zhengding High-tech Industrial Development Zone, No. 71, Menglong Street, South District, Zhengding Area, Shijiazhuang, Hebei Province, 050800, China

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

Hebei Changshan Biochemical Pharmaceutical 300255

Hebei Changshan Biochemical Pharmaceutical Earnings Call Summary

Hebei Changshan Biochemical Pharmaceutical Earnings

Transcripts

Events

About Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

Hebei Changshan Biochemical Pharmaceutical
300255